Rafferty Asset Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$9.99 - $18.71 $1.06 Million - $1.98 Million	-106,041 Reduced 25.72%	306,233 $5.68 Million
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $1.39 Million - $2.93 Million	151,849 Added 58.31%	412,274 $4.56 Million
Q1 2023 May 11, 2023	SELL	$12.53 - $21.71 $68,814 - $119,231	-5,492 Reduced 2.07%	260,425 $3.5 Million
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $468,033 - $649,442	40,313 Added 17.87%	265,917 $3.29 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $884,138 - $1.43 Million	72,411 Added 47.27%	225,604 $3.15 Million
Q2 2022 Aug 12, 2022	SELL	$11.23 - $19.59 $838,319 - $1.46 Million	-74,650 Reduced 32.76%	153,193 $2.12 Million
Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $427,786 - $569,208	-31,996 Reduced 12.31%	227,843 $3.71 Million
Q4 2021 Feb 10, 2022	BUY	$14.28 - $19.53 $1.6 Million - $2.19 Million	112,239 Added 76.04%	259,839 $4.23 Million
Q3 2021 Nov 10, 2021	BUY	$12.99 - $20.47 $345,650 - $544,686	26,609 Added 21.99%	147,600 $2.19 Million
Q2 2021 Aug 10, 2021	SELL	$15.46 - $24.5 $581,311 - $921,224	-37,601 Reduced 23.71%	120,991 $2.42 Million
Q1 2021 May 10, 2021	BUY	$19.33 - $37.75 $2.48 Million - $4.84 Million	128,237 Added 422.46%	158,592 $3.66 Million
Q4 2020 Feb 10, 2021	SELL	$24.48 - $42.47 $421,692 - $731,588	-17,226 Reduced 36.2%	30,355 $750,000
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $1.36 Million - $1.86 Million	34,877 Added 274.54%	47,581 $1.97 Million
Q2 2020 Aug 07, 2020	BUY	$46.7 - $92.04 $413,108 - $814,185	8,846 Added 229.29%	12,704 $609,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $1.4 Million - $3.44 Million	-29,007 Reduced 88.26%	3,858 $243,000
Q4 2019 Feb 10, 2020	SELL	$57.36 - $124.1 $3.51 Million - $7.6 Million	-61,232 Reduced 65.07%	32,865 $4.07 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $1.87 Million - $2.57 Million	31,921 Added 51.34%	94,097 $6.24 Million
Q2 2019 Aug 09, 2019	BUY	$77.77 - $120.68 $1.01 Million - $1.57 Million	13,041 Added 26.54%	62,176 $4.95 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $4.51 Million - $5.93 Million	49,135 New	49,135 $5.5 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account